66
Participants
Start Date
January 22, 2013
Primary Completion Date
May 30, 2014
Study Completion Date
December 11, 2018
Sebelipase Alfa
IV infusions of sebelipase alfa
Placebo
IV infusions of matched placebo
New York
Manhasset
Buffalo
Philadelphia
Wilmington
Cincinnati
Tucson
Palo Alto
San Francisco
Chicago
Boston
Córdoba
Brisbane
New Lambton
Parkville
Perth
Zagreb
Olomouc
Prague
Paris
Vandœuvre-lès-Nancy
Freiburg im Breisgau
Mainz
Munich
Bergamo
Genoa
Padua
Tokyo
Tottori
Mexico City
Warsaw
Moscow
Elche
Madrid
Oviedo
Ankara
Izmir
Cambridge
London
Plymouth
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY